miR-217 inhibits the migration and invasion of HeLa cells through modulating MAPK1

Zhu,Lihong; Yang,Shumei; Wang,Jianfeng

doi:10.3892/ijmm.2019.4328

miR-217 inhibits the migration and invasion of HeLa cells through modulating MAPK1

Authors:
- Lihong Zhu
- Shumei Yang
- Jianfeng Wang
View Affiliations

Affiliations: The Second Clinical Medical College, Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China, Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi 710038, P.R. China, Clinical Laboratory, People's Hospital of Tongchuan, Tongchuan, Shaanxi 727031, P.R. China
Published online on: September 2, 2019 https://doi.org/10.3892/ijmm.2019.4328
Pages: 1824-1832
Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNA (miR)‑217 serves a pivotal role in the progression of colorectal cancer, renal cell carcinoma and glioma, however, the role of miR‑217 in cervical cancer (CC) remains unclear. In the present study, the mechanism of miR‑217 in cervical cancer was explored. The mRNA expression of miR‑217 and mitogen‑activated protein kinase 1 (MAPK1) were assessed using reverse transcription‑quantitative polymerase chain reaction analysis. Cell Counting‑Kit 8, wound‑healing and Transwell assays were performed to detect cell viability, migration and invasion, respectively. Apoptosis and cell cycle were determined by flow cytometry. TargetScan 7.2 and dual‑luciferase reporter assays were respectively used to determine miR‑217 target genes and their binding capacities. The protein expression levels of MAPK1, phosphorylated (p)‑extracellular signal‑regulated kinase 1/2 (ERK1/2)/ERK1/2, Bcl‑2, Bax and cleaved caspase‑3 were quantified by western blotting. It was found that miR‑217 was downregulated in patients with CC and in CC cells. The viability, migration and invasion of cells were suppressed by a miR‑217 mimic. It was also found that apoptosis was increased and cell cycle was inhibited by the miR‑217mimic, which was supported by changes in Bcl‑2, Bax and cleaved caspase‑3. MAPK1 was upregulated in patients with CC and was a target gene of miR‑217. MAPK1 reversed the inhibition of miR‑217 on cell viability, migration, invasion and apoptosis. The protein levels of MAPK1 and p‑ERK1/2, which were higher in the mimic MAPK1 group than those in the control or mimic groups, were ameliorated by PD98059. The results of the present study demonstrated that miR‑217 had an anti‑CC effect and may be effectively used in the treatment of CC.

View Figures

View References

1	Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F and Ferlay J: Worldwide burden of cervical cancer in 2008. Ann Oncol. 22:2675–2686. 2011. View Article : Google Scholar : PubMed/NCBI
2	Cheng L, Guo Y, Zhan S and Xia P: Association between HLA-DP gene polymorphisms and cervical cancer risk: A meta-analysis. Biomed Res Int. 2018.7301595:2018.
3	Guo Z, Shu Y, Zhou H and Zhang W: Identification of diagnostic and prognostic biomarkers for cancer: Focusing on genetic variations in microRNA regulatory pathways (Review). Mol Med Rep. 13:1943–1952. 2016. View Article : Google Scholar : PubMed/NCBI
4	Kwok GT, Zhao JT, Weiss J, Mugridge N, Brahmbhatt H, MacDiarmid JA, Robinson BG and Sidhu SB: Translational applications of microRNAs in cancer, and therapeutic implications. Noncoding RNA Res. 2:143–150. 2017. View Article : Google Scholar
5	Rizzo FM and Meyer T: Liquid biopsies for neuroendocrine tumors: Circulating tumor cells, DNA, and MicroRNAs. Endocrinol Metab Clin North Am. 47:471–483. 2018. View Article : Google Scholar : PubMed/NCBI
6	Su J, Wang Q, Liu Y and Zhong M: miR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3. Mol Cell Biochem. 392:289–296. 2014. View Article : Google Scholar : PubMed/NCBI
7	de Yebenes VG, Bartolomé-Izquierdo N, Nogales-Cadenas R, Pérez-Durán P, Mur SM, Martínez N, Di Lisio L, Robbiani DF, Pascual-Montano A, Cañamero M, et al: miR-217 is an oncogene that enhances the germinal center reaction. Blood. 124:229–239. 2014. View Article : Google Scholar : PubMed/NCBI
8	Chen Q, Wang P, Fu Y, Liu X, Xu W, Wei J, Gao W, Jiang K, Wu J and Miao Y: MicroRNA-217 inhibits cell proliferation, invasion and migration by targeting Tpd52l2 in human pancreatic adeno-carcinoma. Oncol Rep. 38:3567–3573. 2017.PubMed/NCBI
9	Liu P, Yang H, Zhang J, Peng X, Lu Z, Tong W and Chen J: The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma. Sci Rep. 7:51862017. View Article : Google Scholar : PubMed/NCBI
10	Yang J, Zhang HF and Qin CF: MicroRNA-217 functions as a prognosis predictor and inhibits pancreatic cancer cell proliferation and invasion via targeting E2F3. Eur Rev Med Pharmacol Sci. 21:4050–4057. 2017.PubMed/NCBI
11	Jiang C, Yu M, Xie X, Huang G, Peng Y, Ren D, Lin M, Liu B, Liu M, Wang W and Kuang M: miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma. Oncol Rep. 38:2351–2359. 2017. View Article : Google Scholar : PubMed/NCBI
12	Li ZH, Li L, Kang LP and Wang Y: MicroRNA-92a promotes tumor growth and suppresses immune function through activation of MAPK/ERK signaling pathway by inhibiting PTEN in mice bearing U14 cervical cancer. Cancer Med. May 11;2018Epub ahead of print.
13	Zheng HY, Shen FJ, Tong YQ and Li Y: PP2A inhibits cervical cancer cell migration by dephosphorylation of p-JNK, p-p38 and the p-ERK/MAPK signaling pathway. Curr Med Sci. 38:115–123. 2018. View Article : Google Scholar : PubMed/NCBI
14	Xiao M, Feng Y, Cao G, Liu C and Zhang Z: A novel MtHSP70-FPR1 fusion protein enhances cytotoxic T lymphocyte responses to cervical cancer cells by activating human monocyte-derived dendritic cells via the p38 MAPK signaling pathway. Biochem Biophys Res Commun. 503:2108–2116. 2018. View Article : Google Scholar : PubMed/NCBI
15	Zhang D, Li X, Yao Z, Wei C, Ning N and Li J: GABAergic signaling facilitates breast cancer metastasis by promoting ERK1/2-dependent phosphorylation. Cancer Lett. 348:100–108. 2014. View Article : Google Scholar : PubMed/NCBI
16	Shilo A, Ben Hur V, Denichenko P, Stein I, Pikarsky E, Rauch J, Kolch W, Zender L and Karni R: Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development. Rna. 20:505–515. 2014. View Article : Google Scholar : PubMed/NCBI
17	Wang C, Jin H, Gao D, Lieftink C, Evers B, Jin G, Xue Z, Wang L, Beijersbergen RL, Qin W and Bernards R: Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer. J Hepatol. 69:1057–1065. 2018. View Article : Google Scholar : PubMed/NCBI
18	Li Q, Feng Y, Chao X, Shi S, Liang M, Qiao Y, Wang B, Wang P and Zhu Z: HOTAIR contributes to cell proliferation and metastasis of cervical cancer via targetting miR-23b/MAPK1 axis. Biosci Rep. 38:BSR201715632018. View Article : Google Scholar :
19	Tasioudi KE, Saetta AA, Sakellariou S, Levidou G, Michalopoulos NV, Theodorou D, Patsouris E and Korkolopoulou P: pERK activation in esophageal carcinomas: Clinicopathological associations. Pathol Res Pract. 208:398–404. 2012. View Article : Google Scholar : PubMed/NCBI
20	McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, et al: Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 1773:1263–1284. 2007. View Article : Google Scholar
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
22	Burd EM: Human papillomavirus and cervical cancer. Clin Microbiol Rev. 16:1–17. 2003. View Article : Google Scholar : PubMed/NCBI
23	Nour NM: Cervical cancer: A preventable death. Rev Obstet Gynecol. 2:240–244. 2009.
24	Zhou W, Song F, Wu Q, Liu R, Wang L, Liu C, Peng Y, Mao S, Feng J and Chen C: miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5. PLoS One. 12:e01763952017. View Article : Google Scholar : PubMed/NCBI
25	Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
26	Tian YW, Shen Q, Jiang QF, Wang YX, Li K and Xue HZ: Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma. Minerva Med. 108:108–113. 2017.
27	Azam AT, Bahador R, Hesarikia H, Shakeri M and Yeganeh A: Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression, metastasis, and unfavorable prognosis of human osteosarcoma. Tumour Biol. 37:5769–5773. 2016. View Article : Google Scholar
28	Zhang Q, Yuan Y, Cui J, Xiao T and Jiang D: MiR-217 promotes tumor proliferation in breast cancer via targeting DACH1. J Cancer. 6:184–191. 2015. View Article : Google Scholar : PubMed/NCBI
29	Liu YP, Sun XH, Cao XL, Jiang WW, Wang XX, Zhang YF and Wang JL: MicroRNA-217 suppressed epithelial-to-mesenchymal transition in gastric cancer metastasis through targeting PTPN14. Eur Rev Med Pharmacol Sci. 21:1759–1767. 2017.PubMed/NCBI
30	Wang LP, Wang JP and Wang XP: HOTAIR contributes to the growth of liver cancer via targeting miR-217. Oncol Lett. 15:7963–7972. 2018.PubMed/NCBI
31	Salehi B, Zucca P, Sharifi-Rad M, Pezzani R, Rajabi S, Setzer WN, Varoni EM, Iriti M, Kobarfard F and Sharifi-Rad J: Phytotherapeutics in cancer invasion and metastasis. Phytother Res. 32:1425–1449. 2018. View Article : Google Scholar : PubMed/NCBI
32	Cascio S and Finn OJ: Intra- and extra-cellular events related to altered glycosylation of MUC1 promote chronic inflammation, tumor progression, invasion, and metastasis. Biomolecules. 6:E392016. View Article : Google Scholar : PubMed/NCBI
33	Lee CH, Lin YF, Chen YC, Wong SM, Juan SH and Huang HM: MPT0B169 and MPT0B002, new tubulin inhibitors, induce growth inhibition, G2/M cell cycle arrest, and apoptosis in human colorectal cancer cells. Pharmacology. 102:262–271. 2018. View Article : Google Scholar : PubMed/NCBI
34	Tian X, Han Z, Zhu Q, Tan J, Liu W, Wang Y, Chen W, Zou Y, Cai Y, Huang S, et al: Silencing of cadherin-17 enhances apoptosis and inhibits autophagy in colorectal cancer cells. Biomed Pharmacother. 108:331–337. 2018. View Article : Google Scholar : PubMed/NCBI
35	Qian W, Lv S, Li J, Chen K, Jiang Z, Cheng L, Zhou C, Yan B, Cao J, Ma Q and Duan W: Norepinephrine enhances cell viability and invasion, and inhibits apoptosis of pancreatic cancer cells in a Notch-1-dependent manner. Oncol Rep. 40:3015–3023. 2018.PubMed/NCBI
36	Soleimani A, Bahreyni A, Roshan MK, Soltani A, Ryzhikov M, Shafiee M, Soukhtanloo M, Jaafari MR, Mashkani B and Hassanian SM: Therapeutic potency of pharmacological adenosine receptors agonist/antagonist on cancer cell apoptosis in tumor microenvironment, current status, and perspectives. J Cell Physiol. 234:2329–2336. 2018. View Article : Google Scholar : PubMed/NCBI
37	Orton RJ, Sturm OE, Vyshemirsky V, Calder M, Gilbert DR and Kolch W: Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway. Biochem J. 392:249–261. 2005. View Article : Google Scholar : PubMed/NCBI
38	Kyriakis JM: Making the connection: Coupling of stress-activated ERK/MAPK (extracellular-signal-regulated kinase/mitogen-activated protein kinase) core signalling modules to extracellular stimuli and biological responses. Biochem Soc Symp. 64:29–48. 1999.PubMed/NCBI
39	Zhang Y, Meng L, Xiao L, Liu R, Li Z and Wang YL: The RNA-binding protein PCBP1 functions as a tumor suppressor in prostate cancer by inhibiting mitogen activated protein kinase 1. Cell Physiol Biochem. 48:1747–1754. 2018. View Article : Google Scholar : PubMed/NCBI
40	Zhang N, Lu C and Chen L: miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer. Oncol Lett. 12:4589–4597. 2016. View Article : Google Scholar
41	Hu L, Wu H, Wan X, Liu L, He Y, Zhu L, Liu S, Yao H and Zhu Z: MicroRNA-585 suppresses tumor proliferation and migration in gastric cancer by directly targeting MAPK1. Biochem Biophys Res Commun. 499:52–58. 2018. View Article : Google Scholar : PubMed/NCBI